Cue Health makes De Novo submission to FDA for full clearance of its Cue Flu Molecular Test
Cue Health (“Cue”) ( Nasdaq: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue® Flu Molecular